XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:    
Net income $ 101,755 $ 14,044
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 57,951 64,198
Special charges 8,309  
Non-cash interest expense 941 679
Non-cash stock compensation expense 13,015 15,021
Non-cash income tax provision (benefit) (29,443) 1,026
Non-cash (amortization) accretion on investments 907 (327)
Changes in assets and liabilities, net of effects from acquisitions of businesses:    
Accounts receivable, net (24,535) (51,544)
Pharmaceutical inventory 8,268 (4,793)
Other assets (38,322) (23,890)
Accounts payable and accrued liabilities 62,970 20,821
Medical claims payable and other medical liabilities 10,510 4,329
Contingent consideration   (3,758)
Tax contingencies 1,343 610
Deferred credits and other long-term liabilities (2,537) (7,429)
Other (289) 372
Net cash provided by operating activities 170,843 29,359
Net cash (used in) provided by operating activities from discontinued operations 178,326 (16,574)
Net cash provided by (used in) operating activities from continuing operations (7,483) 45,933
Cash flows from investing activities:    
Capital expenditures (38,305) (27,804)
Acquisitions and investments in businesses, net of cash acquired (369) (320)
Purchases of investments (417,688) (295,768)
Proceeds from maturities and sales of investments 288,137 288,290
Net cash used in investing activities (168,225) (35,602)
Net cash used in investing activities from discontinued operations (156,800) (3,210)
Net cash used in investing activities from continuing operations (11,425) (32,392)
Cash flows from financing activities:    
Proceeds from borrowings on revolving line of credit 80,000  
Payments to acquire treasury stock   (4,124)
Proceeds from exercise of stock options 29,825 20,647
Payments on debt, finance lease and deferred financing obligations (40,264) (15,543)
Payments on contingent consideration   (6,247)
Other (1,136) (446)
Net cash (used in) provided by financing activities 68,425 (5,713)
Net cash provided by financing activities from discontinued operations 4,850  
Net cash (used in) provided by financing activities from continuing operations 63,575 (5,713)
Net increase in cash and cash equivalents from continuing operations 44,667 7,828
Cash and cash equivalents at beginning of period 115,752 86,923
Cash and cash equivalents at end of period 160,419 94,751
Non-cash investing activities:    
Assets acquired under finance leases and deferred financing obligations $ 3,599 $ 3,302